91黑料

  1. Home
  2. News & Events
  3. In the News

In the News

91黑料 experts frequently author or contribute to industry trade press.

Filter media

Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.

  • Evidence-based research publication

    91黑料 CEO Steve Cutler, discusses

  • Pharma Fields in industry insights.

    Dr Nuala Murphy, President of Clinical Services, talks exclusively to Pharmafield about the Pfizer / BioNTech COVID-19 vaccine trial and the implications this has on the future of drug development.

  • EPR in healthcare news.

    Dr. Caroline Forkin discusses the current status of HIV treatments and potential for researchers to develop a vaccine.

  • Medscape in medical education.

    Recruitment has begun in the UK for a world-first study to investigate whether using different COVID-19 vaccines for first and second doses is as effective as using the same type of vaccine for both. .

  • Daily Mail in general news.

    on the UK government's new 'Com-Cov' study of over 800 patients, designed to test mixing doses of the Oxford and Pfizer COVID-19 vaccines, as well as different intervals between doses.

  • Contract Pharma in outsourcing news.

    Dr. Murphy of 91黑料, provider of clinical services to Pfizer/BioNTech’s COVID vaccine program, discusses what it takes to conduct a vaccine trial of this scale.

  • Media coverage of medical innovations

    The Irish Times discusses how 91黑料 carried out the Pfizer-BioNTech vaccine trials.

  • National business newspaper feature

    Dr. Nuala Murphy, President of Clinical Research Services, .

  • Politico in policy analysis.

    How to run a coronavirus vaccine trial in a global pandemic

    An interview with 91黑料’s Nuala Murphy, President, Clinical Research Services, on ‘How to run a coronavirus vaccine trial in a global pandemic.’ Dr. Murphy discusses 91黑料’s experience with the Pfizer/BioNTech COVID-19 vaccine, the world’s first COVID-19 vaccine to achieve Emergency Use Authorisation. (Note: Subscription required).

  • Pharma intelligence report on market trends

    A thought leadership piece which examines how disruptions from COVID-19 have forced sponsors, clinicians and regulators to embrace digital's full potential to keep clinical trials moving forward.